Detalles de la búsqueda
1.
Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma.
Int J Mol Sci
; 20(22)2019 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31752449
2.
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice.
Cancer Biomark
; 38(3): 301-309, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545217
3.
Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma.
Sci Rep
; 13(1): 7781, 2023 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37179432
4.
Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.
Tumori
; 109(5): 458-465, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36942354
5.
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei.
Biomedicines
; 11(7)2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509688
6.
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.
Front Oncol
; 13: 1307545, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406172
7.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Clin Lung Cancer
; 24(7): 631-640.e2, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775370
8.
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.
JCO Precis Oncol
; 7: e2300067, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487147
9.
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.
Front Oncol
; 12: 857515, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35463374
10.
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples.
Explor Target Antitumor Ther
; 3(5): 582-597, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36338518
11.
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.
JCO Precis Oncol
; 6: e2200015, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35476549
12.
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial.
J Clin Oncol
; 40(14): 1562-1573, 2022 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258987
13.
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib.
Thorac Cancer
; 12(13): 2031-2034, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34008923
14.
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.
J Clin Oncol
; 39(36): 4061-4068, 2021 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597119
15.
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients.
Clin Colorectal Cancer
; 20(4): 314-317, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364814
16.
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
J Thorac Oncol
; 16(8): 1298-1311, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887464
17.
Identification of potentially druggable molecular alterations in skin adnexal malignancies.
J Dermatol
; 46(6): 507-514, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31038235
18.
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.
J Pathol Clin Res
; 3(2): 139-152, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451462
19.
Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.
Virchows Arch
; 471(1): 31-47, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451756
20.
A rare biclonal Hairy Cell Leukemia disclosed by an integrated diagnostic approach: A case report.
Cytometry B Clin Cytom
; 100(6): 692-694, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33337573
Resultados
1 -
20
de 20
1
Próxima >
>>